MBI Pharma’s highly professional team offers our partners individually tailored solutions. The company, its partners and its team all comply with internationally accepted standards of Good Manufacturing Practice (GMP), Good Distribution Practice (GDP) and Good Promotional Practice (GPP).
MBI Pharma is a niche pharmaceutical company specializing in the commercialization of pharmaceutical products into Israel. MBI team members use their expertise and market intelligence to understand local market requirements, and assist manufacturers to commercialize their products in the market.
Established in 2010, MBI Pharma is the Israeli subsidiary of Mawdsley Brooks UK Ltd, a company, established nearly 200 years ago that has a strong domestic and international presence in specialty pharmaceuticals.
Unlicensed Sales (29C)
Full Product Registration
Marketing and Sales Team
Specialized Brand Management
Regulatory, Pharmacovigilance & Medical Affairs
Distribution & Logistics
